More Globe Newswire

View Older Stories View Newer Stories

Feb 27, 2024 07:30AM FirstService Residential Further Enhances Market Leadership Position in Florida
Feb 27, 2024 07:30AM Fireweed Makes Complete Drill Database Available and Launches New Website
Feb 27, 2024 07:30AM Norwegian Cruise Line Holdings Reports Strong Fourth Quarter and Full Year 2023 Financial Results
Feb 27, 2024 07:30AM TG Therapeutics Announces Issuance of Additional Patents for BRIUMVI® (ublituximab-xiiy)
Feb 27, 2024 07:30AM Vanqua Bio to Present Pre-Clinical Data on VQ-101, a Novel GCase Activator For The Treatment of GBA-Parkinson’s Disease
Feb 27, 2024 07:30AM Theratechnologies Receives Refusal to File Letter for Trogarzo® Intramuscular Method of Administration sBLA from FDA
Feb 27, 2024 07:30AM Verve Therapeutics Provides Pipeline Progress and Reports Fourth Quarter and Full Year 2023 Financial Results
Feb 27, 2024 07:30AM Nexxen to Announce Fourth Quarter 2023 Financial Results on March 6, 2024
Feb 27, 2024 07:30AM Verrica Pharmaceuticals Announces Participation in the TD Cowen 44th Annual Healthcare Conference
Feb 27, 2024 07:30AM Tourmaline Bio to Present at Upcoming Investor Conferences
Feb 27, 2024 07:25AM AGF Investments Launches Additional ETF Series
Feb 27, 2024 07:25AM Arch Biopartners Has Pre-IND Meeting With FDA to Discuss Repurposing Cilastatin as a New Treatment to Prevent Acute Kidney Injury
Feb 27, 2024 07:12AM Form 8.3 - Young & Co Brewery Plc
Feb 27, 2024 07:10AM Form 8.3 - UK Commercial Property REIT
Feb 27, 2024 07:07AM EnviroGold Global Announces Positive Initial Test Results with a Second Major Global Metal Production Company
Feb 27, 2024 07:05AM Kraig Biocraft Laboratories Establishes Homozygosity and Confirms BAM 1 Hybrid Optimized Ahead of Spring Production Trials
Feb 27, 2024 07:05AM Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
Feb 27, 2024 07:02AM Form 8.3 - [YOUNG & CO.'S BREWERY PLC - 26 02 2024] - (CGWL)
Feb 27, 2024 07:00AM Marimaca to Present at the BMO 2024 Global Metals, Mining and Critical Minerals Conference – Live Webinar
Feb 27, 2024 07:00AM ChampionX acquires Artificial Lift Performance Limited to expand digital solutions portfolio
Feb 27, 2024 07:00AM Sotera Health Reports Fourth-Quarter and Full-Year 2023 Results; Provides 2024 Outlook
Feb 27, 2024 07:01AM ENGIE announces $1bn Tax Equity Financing for more than 1.3 GW of U.S. Renewables Assets
Feb 27, 2024 07:01AM The BIG 615’s The Storme Warren Show is Now Available Through ‘CountryLine: The BIG 615’ in the United Kingdom
Feb 27, 2024 07:00AM Passage Bio to Participate in Upcoming Investor Conferences
Feb 27, 2024 07:00AM CannMart Reports Growth in Key Markets of Alberta and Ontario with In-house Brand Roilty Ranking as the Second Best-Selling Concentrate in 2023
Feb 27, 2024 07:00AM Nevada Lithium intersects 4,154 ppm Lithium over 680 ft (207 m); Confirms laterally extensive, high-grade mineralization at Bonnie Claire Lithium Project, Nevada
Feb 27, 2024 07:00AM R1 RCM Reports Fourth Quarter and Full Year 2023 Results
Feb 27, 2024 07:00AM Arvinas Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Feb 27, 2024 07:00AM Purple Biotech Presents Data of its Phase 1 Head & Neck Cancer of NT219 in combination with Cetuximab at ESMO TAT Congress 2024
Feb 27, 2024 07:00AM Augmedix to Participate in Citizens JMP Technology Conference
Feb 27, 2024 07:00AM Zentalis Pharmaceuticals Reports Full Year 2023 Financial Results and Operational Updates
Feb 27, 2024 07:00AM Refined Metals Corp. and Eagle Plains Resources Enter into an Option Agreement for the Dufferin Project in the Athabasca Basin
Feb 27, 2024 07:00AM DT Midstream Sets 2024 Annual Meeting Date
Feb 27, 2024 07:00AM EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences
Feb 27, 2024 07:00AM Chimerix to Present at TD Cowen 44th Annual Health Care Conference
Feb 27, 2024 07:00AM Bartlett and Regrow Partner to Advance Sustainability Commitments
Feb 27, 2024 07:00AM Purple Biotech Presents Data of its Phase 1 Head & Neck Cancer of NT219 in combination with Cetuximab at ESMO TAT Congress 2024
Feb 27, 2024 07:00AM Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2023
Feb 27, 2024 07:00AM Canoo Successfully Completes First Hiring Milestone and Receives Non-Dilutive Incentives from Oklahoma
Feb 27, 2024 07:00AM ATHA Energy Announces Appointment of Ryan Gaffney as Senior Vice President, Business Development
Feb 27, 2024 07:00AM Amplify ETFs Declares February Income Distributions for its ETFs
Feb 27, 2024 07:00AM Good Supply Launches New ‘Juiced’ Cannabis Pre-Roll Multi-Packs Across Canada
Feb 27, 2024 07:00AM Bolt Biotherapeutics to Present at the TD Cowen 44th Annual Healthcare Conference
Feb 27, 2024 07:00AM Malibu Boats, Inc. to Participate at the Raymond James 2024 Institutional Investors Conference
Feb 27, 2024 07:00AM Company Generates Record Subscriptions Sales for 2023 Holiday Season
Feb 27, 2024 07:00AM Monopar Provides Update on MNPR-101-Zr Radiopharma Clinical Trial
Feb 27, 2024 07:00AM Mural Oncology to Present at the TD Cowen 44th Annual Health Care Conference
Feb 27, 2024 07:00AM New Look Chooses Dayforce to Transform HR and Payroll
Feb 27, 2024 07:00AM Aclaris Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update
Feb 27, 2024 07:00AM Monaghan Medical Corporation Attains ISO 14001 Certification for Environmental Management Excellence
View Newer Stories View Older Stories